Particle Design
Building LNPs around desired properties from the beginning.
Next-generation lipid nanoparticles
A frontier biotechnology company developing a differentiated approach to particle design.
Why this matters
RNA medicines are advancing.
Delivery systems have not kept pace.
Lipid nanoparticles are the leading non-viral delivery system for RNA and DNA medicines. Yet the field still depends on particles that are difficult to control, hard to tune, and often discovered through extensive empirical screening.
BIZON Labs is built around a simple belief: the next generation of LNPs should be designed more intentionally from the beginning.
The name BIZON is a nod to bison, which are known for turning into a storm and moving through it rather than away from it. We take the same posture in science: walking directly toward hard delivery challenges with focus, patience, and conviction.
The belief
Particles should not only be screened into existence. They should be built around the properties we want them to have.
The build
From process to particle architecture.
Our work sits at the interface of formulation, process development, and delivery biology.
The platform
A differentiated way to build particles.
Rather than treating formulation as an empirical search problem, BIZON is developing a framework for designing particles around the properties we want them to have. Our work connects process development, particle architecture, and biological performance.
Structural Control
Exploring how process innovations can influence LNP architecture.
Delivery Biology
Mapping the relationship between LNP architecture and complex biological systems.
Translational Readiness
Developing with real-world therapeutic applications in mind, and scalable by design.
Proof of depth
The full-time team behind BIZON Labs has authored
60+
papers
1,500+
citations
Conversations
Open to scientific and development conversations.
We welcome conversations with collaborators, investors, and strategic partners whose work touches formulation, characterization, translation, or delivery.
The Herd
The people walking into the hard problems.
BIZON Labs is led by co-founders Peter Sagmeister, Aniket Udepurkar, and Cedric Devos, bringing together experience across formulation, self-assembly, translational science, company formation, and biotechnology operations, with support and mentorship from a broader group of scientific, clinical, and company-building advisors.
Peter Sagmeister
Co-founder & Chief Executive Officer
Founder and company builder with experience advancing biotechnology platforms.
LinkedInAniket Udepurkar
Co-founder & Chief Technology Officer
Scientist focused on formulation, materials, and differentiated particle design.
LinkedInCedric Devos
Co-founder & Chief Operating Officer
Operator and scientist supporting company strategy, execution, and external partnerships.
LinkedInInvitation
For scientific, partnership, investment, and career conversations.
We welcome conversations with people interested in the future of lipid nanoparticle technology.
office@bizonlabs.com